(Q39465507)

12 September 2017

title

miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy (English)

1 reference

12 September 2017

0 references

2

1 reference

12 September 2017

14

1 reference

12 September 2017

Gianfranco Mattia

11

0 references

Piero Picci

object named as

Piero Picci

13

0 references

Massimo Negrini

object named as

Massimo Negrini

12

0 references

Maria Cristina Manara

3

object named as

Maria Cristina Manara

1 reference

12 September 2017

7

Marco Alberghini

1 reference

12 September 2017

15

Katia Scotlandi

1 reference

12 September 2017

4

Selena Ventura

1 reference

12 September 2017

9

Sakari Knuutila

1 reference

12 September 2017

Fumihiko Nakatani

1

1 reference

12 September 2017

Valentina Del Monaco

5

1 reference

12 September 2017

Stefano Ferrari

6

1 reference

12 September 2017

Andrea Grilli

8

1 reference

12 September 2017

Karl-Ludwig Schaefer

10

1 reference

12 September 2017

publication date

1 April 2012

1 reference

12 September 2017

1 reference

12 September 2017

volume

226

1 reference

12 September 2017

issue

5

1 reference

12 September 2017

page(s)

796-805

1 reference

Mechanisms of sarcoma development

12 September 2017

cites work

1 reference

EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cells

21 January 2018

1 reference

Identification of cancer stem cells in Ewing's sarcoma

21 January 2018

1 reference

Mesenchymal stem cell features of Ewing tumors

21 January 2018

1 reference

Approaching Ewing sarcoma

21 January 2018

1 reference

Bone and soft tissue sarcomas are often curable--but at what cost?: a call to arms (and legs).

21 January 2018

1 reference

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

miRNAs as molecular biomarkers of cancer

21 January 2018

1 reference

Micromarkers: miRNAs in cancer diagnosis and prognosis.

21 January 2018

1 reference

Unique MicroRNA signature and clinical outcome of cancers

21 January 2018

1 reference

Prognostic factors in non-metastatic Ewing's sarcoma tumor of bone: an analysis of 579 patients treated at a single institution with adjuvant or neoadjuvant chemotherapy between 1972 and 1998.

21 January 2018

1 reference

Power and sample size calculations for studies involving linear regression

21 January 2018

1 reference

Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues

21 January 2018

1 reference

Semi-supervised methods to predict patient survival from gene expression data

21 January 2018

1 reference

A microRNA component of the p53 tumour suppressor network

21 January 2018

1 reference

Molecular characterization of commonly used cell lines for bone tumor research: a trans-European EuroBoNet effort

21 January 2018

1 reference

The miR-34 family in cancer and apoptosis

21 January 2018

1 reference

Ewing sarcomas with p53 mutation or p16/p14ARF homozygous deletion: a highly lethal subset associated with poor chemoresponse

21 January 2018

1 reference

Microarray analysis of Ewing's sarcoma family of tumours reveals characteristic gene expression signatures associated with metastasis and resistance to chemotherapy

21 January 2018

1 reference

21 January 2018

1 reference

Small-molecule inhibitors of the MDM2-p53 protein-protein interaction to reactivate p53 function: a novel approach for cancer therapy

21 January 2018

1 reference

Nutlin-3a activates p53 to both down-regulate inhibitor of growth 2 and up-regulate mir-34a, mir-34b, and mir-34c expression, and induce senescence

21 January 2018

1 reference

Intercohort gene expression co-analysis reveals chemokine receptors as prognostic indicators in Ewing's sarcoma

21 January 2018

1 reference

Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells

21 January 2018

1 reference

Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer

21 January 2018

1 reference

MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells

21 January 2018

1 reference

Functional elucidation of MiR-34 in osteosarcoma cells and primary tumor samples

21 January 2018

1 reference

Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest

21 January 2018

1 reference

MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types

21 January 2018

1 reference

The guardian's little helper: microRNAs in the p53 tumor suppressor network

21 January 2018

1 reference

p53 enters the microRNA world

21 January 2018

1 reference

Inhibition of the transcriptional function of p53 by EWS-Fli1 chimeric protein in Ewing Family Tumors

21 January 2018

1 reference

Nutlin-3a is a potential therapeutic for ewing sarcoma

21 January 2018

1 reference

MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells

21 January 2018

1 reference

Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34

21 January 2018

1 reference

The Ewing Family of Tumors -- A Subgroup of Small-Round-Cell Tumors Defined by Specific Chimeric Transcripts

21 January 2018

1 reference

Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PATH.3007

1 reference

12 September 2017

1 reference